| Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche A Shinde, JS Paez, S Libring, K Hopkins, L Solorio, MK Wendt Oncogenesis 9 (2), 16, 2020 | 105 | 2020 |
| Spleen tyrosine kinase–mediated autophagy is required for epithelial–mesenchymal plasticity and metastasis in breast cancer A Shinde, SD Hardy, D Kim, SS Akhand, MK Jolly, WH Wang, ... Cancer research 79 (8), 1831-1843, 2019 | 103 | 2019 |
| Autocrine fibronectin inhibits breast cancer metastasis A Shinde, S Libring, A Alpsoy, A Abdullah, JA Schaber, L Solorio, ... Molecular cancer research 16 (10), 1579-1589, 2018 | 100 | 2018 |
| The dynamic relationship of breast cancer cells and fibroblasts in fibronectin accumulation at primary and metastatic tumor sites A Shinde, S Libring, MK Chanda, M Nuru, H George, AM Saleh, ... Cancers 12 (5), 1270, 2020 | 78 | 2020 |
| Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer A Shinde, T Wilmanski, H Chen, D Teegarden, MK Wendt Breast cancer research 20, 1-12, 2018 | 78 | 2018 |
| Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy SD Hardy, A Shinde, WH Wang, MK Wendt, RL Geahlen Oncotarget 8 (61), 103302, 2017 | 76 | 2017 |
| Inhibition of pyruvate carboxylase by 1α, 25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression T Wilmanski, X Zhou, W Zheng, A Shinde, SS Donkin, M Wendt, ... Cancer letters 411, 171-181, 2017 | 72 | 2017 |
| Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases G Uzunalli, AM Dieterly, CM Kemet, HY Weng, AH Soepriatna, ... Oncotarget 10 (59), 6334, 2019 | 40 | 2019 |
| Peptide internalization enabled by folding: triple helical cell‐penetrating peptides A Shinde, KM Feher, C Hu, K Slowinska Journal of Peptide Science 21 (2), 77-84, 2015 | 37 | 2015 |
| Fibronectin-expressing mesenchymal tumor cells promote breast cancer metastasis BH Jun, T Guo, S Libring, MK Chanda, JS Paez, A Shinde, MK Wendt, ... Cancers 12 (9), 2553, 2020 | 25 | 2020 |
| Toxicity mechanism in fetal lung fibroblast cells for multi-walled carbon nanotubes defined by chemical impurities and dispersibility A Shinde, CSJ Tsai Toxicology research 5 (1), 248-258, 2016 | 16 | 2016 |
| Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer A Shinde, E Kulkoyluoglu Cotul, H Chen, A Smith, S Libring, L Solorio, ... Molecular biomedicine 3 (1), 19, 2022 | 5 | 2022 |
| A Phase 1 Relative Bioavailability Study of Omaveloxolone Intact Capsules vs. Contents Sprinkled on Applesauce in Healthy Adult Subjects S Hynes, A Shinde, H Zahir, M Murai, S Khan, T Wu, L Wu MDA Conference, 2024 | | 2024 |
| Population Pharmacokinetics Analysis of Bardoxolone Methyl in Healthy Subjects and Subjects with Chronic Kidney Diseases S Hynes, H Zahir, A Shinde, YW Lin, L Strong, M Hasegawa, W Copalu, ... American Conference on Pharmacometrics, 2023 | | 2023 |
| Pharmacometric Model to Describe the Relationship between Bardoxolone Methyl Exposure and Estimated Glomerular Filtration Rate Changes in Patients with Chronic Kidney Disease … S Hynes, H Zahir, A Shinde, L Strong, William,Copalu, N Teuscher, ... American Conference on Pharmacometrics, 2023 | | 2023 |
| A retrospective Pooled Concentration-QTc Analysis for Omaveloxolone Using Plasma Concentration and Electrocardiogram Data from Clinical Pharmacology Studies H Zahir, A Shinde, S Hynes American Conference on Pharmacometrics, 2023 | | 2023 |
| Development of a Population Pharmacokinetic Model of Omaveloxolone A Shinde, S Hynes, H Zahir, E Freshwater, N Teuscher American Conference on Pharmacometrics, 2023 | | 2023 |
| A Phase 1, Randomized, Open-label, Single-Dose, Crossover, Relative Bioavailability Study of Omaveloxolone Intact Capsules versus Capsule Contents Sprinkled on Applesauce in … S Hynes, A Shinde, H Zahir American Association of Pharmaceutical Scientists, 2023 | | 2023 |
| Development, Verification & Application of Physiologically-based Pharmacokinetic Model to Evaluate the CYP3A4-mediated Drug-Drug Interactions Potential of Omaveloxolone A Shinde, H Zahir, S Hynes, S Gahir, A Jones, Hannah, KeZamek, N Patel American College of Clinical Pharmacology® (ACCP) 12 (1), 25-27, 2023 | | 2023 |
| A Phase1, Open-Label, 4-Part, Drug-Drug Interaction Study With Omaveloxolone in Healthy Subjects A Shinde, S Hynes, C Meyer, H Zahir, Proksch, Joel American College of Clinical Pharmacology® (ACCP) 12, 79-80, 2023 | | 2023 |
Michael K WendtAssociate Professor of Pharmacology, Purdue UniversityVerified email at purdue.edu
